Canna edulis RS3 resistant starch:Canna edulis RS3 resistant starch treatment

2 trials

Sponsors

Beijing University of Chinese Medicine

Conditions

mild hyperlipidemiamild hyperlipidemia combined with obesity

Phase 1

Clinical study on anti-mild hyperlipidemia of Canna edulis RS3 resistant starch

Active, not recruitingChiCTR2200062871

Beijing University of Chinese Medicinemild hyperlipidemia

Start: 2022-09-01Updated: 2023-04-12

Clinical study of Canna edulis RS3 resistant starch resistant to mild hyperlipidemia clinical research

Active, not recruitingChiCTR2300069520

Beijing University of Chinese Medicinemild hyperlipidemia combined with obesity

Start: 2023-03-20Updated: 2023-05-29

Related Papers

Type 3 resistant starch from Canna edulis reduce lipid levels in patients with mild hyperlipidemia through altering gut microbiome: A double- blind randomized controlled trial

Pharmacological Research2024-06-0116 citations